Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Prevail Therapeutics Inc. (PRVL)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 34,250,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile  


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 23
  Page 1 of 1  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Minkow Emily Chief Business Officer   •       –      –    2021-01-22 4 D $0.00 $0 D/D (13,000) 0     -
   Thompson Peter A Director   –       •       •   2021-01-22 4 D $0.00 $0 I/I (13,822,463) 0     -
   Orbimed Capital Gp Vi Llc Director   –       •       •   2021-01-22 4 D $0.00 $0 I/I (13,822,463) 0     -
   Nussbaum Ran Director   –       •      –    2021-01-22 4 D $0.00 $0 I/I (1,576,881) 0     -
   Gordon Carl L Director   –       •       •   2021-01-22 4 D $0.00 $0 I/I (13,822,463) 0     -
   Abeliovich Asa President & CEO   •       •      –    2021-01-22 4 D $0.00 $0 D/D (2,385,756) 0     -
   Nader Francois Director   –       •      –    2021-01-22 4 D $0.00 $0 I/I (23,747) 0     -
   Lilly Eli & Co 10% Owner   –       –       •   2021-01-22 4 B $22.50 $771,407,753 D/D 34,284,789 100 2.45     -
   Abeliovich Asa President & CEO   •       •      –    2020-12-30 4 D $23.02 $2,049,632 D/D (89,037) 2,385,756     -
   Abeliovich Asa President & CEO   •       •      –    2020-12-30 4 OE $0.18 $1,237,656 D/D 125,793 2,474,793     -
   Minkow Emily Chief Business Officer   •       –      –    2019-12-24 4 OE $0.18 $2,340 D/D 13,000 13,000     -
   Gordon Carl L Director   –       •       •   2019-06-24 4 B $17.00 $14,999,984 I/I 882,352 13,822,463 2.25     -
   Gordon Carl L Director   –       •       •   2019-06-24 4 A $0.00 $0 I/I 10,510,111 12,940,111     -
   Orbimed Capital Gp Vi Llc Director   –       •       •   2019-06-24 4 B $17.00 $14,999,984 I/I 882,352 13,822,463 2.25     -
   Orbimed Capital Gp Vi Llc Director   –       •       •   2019-06-24 4 A $0.00 $0 I/I 10,510,111 12,940,111     -
   Thompson Peter A Director   –       •       •   2019-06-24 4 B $17.00 $14,999,984 I/I 882,352 13,822,463 2.25     -
   Thompson Peter A Director   –       •       •   2019-06-24 4 A $0.00 $0 I/I 10,510,111 12,940,111     -
   Nader Francois Director   –       •      –    2019-06-24 4 A $0.00 $0 I/I 23,747 23,747     -
   Gordon Carl L Director   –       •       •   2019-06-19 3 IO $0.00 $0 I/I 0 2,430,000     -
   Thompson Peter A Director   –       •       •   2019-06-19 3 IO $0.00 $0 I/I 0 2,430,000     -
   Orbimed Capital Gp Vi Llc Director   –       •       •   2019-06-19 3 IO $0.00 $0 I/I 0 2,430,000     -
   Abeliovich Asa President & CEOOfficer   •       •       •   2019-06-19 3 IO $0.00 $0 D/D 0 2,349,000     -
   Nussbaum Ran Director   –       •      –    2019-06-19 3 IO $0.00 $0 I/I 0 1,576,881     -

  23 Records found
  1    
  Page 1 of 1
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed